Drug – bio-affecting and body treating compositions – Radionuclide or intended radionuclide containing; adjuvant... – In an organic compound
Reexamination Certificate
2007-06-21
2009-12-22
Jones, D L (Department: 1618)
Drug, bio-affecting and body treating compositions
Radionuclide or intended radionuclide containing; adjuvant...
In an organic compound
C424S001110, C424S001490, C424S001690, C424S001730, C514S773000, C514S002600
Reexamination Certificate
active
07635463
ABSTRACT:
This disclosure relates to compositions for delivering agents to a subject, and in particular, to compositions for delivery of therapeutic agents or diagnostic agents in the presence or absence of targeting moieties. In part, this disclosure relates to compositions comprising a hydrophobic group with a first end and a second end, a first metal binding domain linked to the hydrophobic group, a metal ion capable of being chelated to the first metal binding domain, and an agent linked to a second metal binding domain capable of chelating to the metal ion.
REFERENCES:
patent: 4857311 (1989-08-01), Domb et al.
patent: 5118666 (1992-06-01), Habener
patent: 5120712 (1992-06-01), Habener
patent: 5527524 (1996-06-01), Tomalia et al.
patent: 5554388 (1996-09-01), Illum
patent: 5593658 (1997-01-01), Bogdanov et al.
patent: 5605672 (1997-02-01), Bogdanov et al.
patent: 5614492 (1997-03-01), Habener
patent: 5631018 (1997-05-01), Zalipsky et al.
patent: 5661025 (1997-08-01), Szoka, Jr. et al.
patent: 5663387 (1997-09-01), Singh
patent: 5681544 (1997-10-01), Schmitt-Willich et al.
patent: 5714166 (1998-02-01), Tomalia et al.
patent: 5744166 (1998-04-01), Illum
patent: 5763585 (1998-06-01), Nag
patent: 5837747 (1998-11-01), Soon-Shiong et al.
patent: 5871710 (1999-02-01), Bogdanov et al.
patent: 5891418 (1999-04-01), Sharma
patent: 5958909 (1999-09-01), Habener
patent: 5977084 (1999-11-01), Szoka, Jr. et al.
patent: 6006753 (1999-12-01), Efendic
patent: 6051549 (2000-04-01), Roberts et al.
patent: 6113946 (2000-09-01), Szoka, Jr. et al.
patent: 6124273 (2000-09-01), Drohan et al.
patent: 6162462 (2000-12-01), Bolotin et al.
patent: 6274175 (2001-08-01), Gombotz et al.
patent: 6284727 (2001-09-01), Kim et al.
patent: 6338859 (2002-01-01), Leroux et al.
patent: 6348069 (2002-02-01), Vacanti et al.
patent: 6365173 (2002-04-01), Domb et al.
patent: 6395299 (2002-05-01), Babich et al.
patent: 6443898 (2002-09-01), Unger et al.
patent: 6447753 (2002-09-01), Edwards et al.
patent: 6458373 (2002-10-01), Lambert et al.
patent: 6468532 (2002-10-01), Hsei et al.
patent: 6475779 (2002-11-01), Mathiowitz et al.
patent: 6492560 (2002-12-01), Wilbur et al.
patent: 6509323 (2003-01-01), Davis et al.
patent: 6521211 (2003-02-01), Unger et al.
patent: 6521736 (2003-02-01), Watterson et al.
patent: 6579851 (2003-06-01), Goeke et al.
patent: 6583111 (2003-06-01), DiMarchi et al.
patent: 6586524 (2003-07-01), Sagara et al.
patent: 6589549 (2003-07-01), Shih et al.
patent: 6627228 (2003-09-01), Milstein et al.
patent: 6703037 (2004-03-01), Hubbell et al.
patent: 6703359 (2004-03-01), Young et al.
patent: 6706689 (2004-03-01), Coolidge et al.
patent: 6747006 (2004-06-01), Efendic
patent: 6828303 (2004-12-01), Kim et al.
patent: 6849708 (2005-02-01), Habener
patent: 6884628 (2005-04-01), Hubbell et al.
patent: 6894024 (2005-05-01), Coolidge et al.
patent: 6899883 (2005-05-01), Dupre
patent: 6982248 (2006-01-01), Coolidge et al.
patent: 6998137 (2006-02-01), Shih et al.
patent: 7049284 (2006-05-01), Drucker
patent: 7101843 (2006-09-01), Glaesner et al.
patent: 7138105 (2006-11-01), Bolotin
patent: 7138486 (2006-11-01), Habener
patent: 7144863 (2006-12-01), DeFelippis et al.
patent: 7199217 (2007-04-01), DiMarchi et al.
patent: 7259233 (2007-08-01), Dodd et al.
patent: 2002/0132254 (2002-09-01), Twu
patent: 2003/0050237 (2003-03-01), Kim et al.
patent: 2003/0119734 (2003-06-01), Flink et al.
patent: 2003/0220251 (2003-11-01), Knudsen et al.
patent: 2003/0224974 (2003-12-01), Bolotin
patent: 2003/0229034 (2003-12-01), Waugh et al.
patent: 2004/0092432 (2004-05-01), During et al.
patent: 2004/0162241 (2004-08-01), Efendic
patent: 2004/0197369 (2004-10-01), Hubbell et al.
patent: 2004/0209803 (2004-10-01), Baron et al.
patent: 2004/0220105 (2004-11-01), Jensen et al.
patent: 2004/0235726 (2004-11-01), Jakubowski et al.
patent: 2004/0266683 (2004-12-01), Hathaway et al.
patent: 2005/0008661 (2005-01-01), Fereira et al.
patent: 2005/0014681 (2005-01-01), Minamitake et al.
patent: 2005/0143303 (2005-06-01), Quay et al.
patent: 2005/0148497 (2005-07-01), Khan et al.
patent: 2005/0159356 (2005-07-01), Dong et al.
patent: 2005/0215475 (2005-09-01), Ong et al.
patent: 2005/0239705 (2005-10-01), Dake et al.
patent: 2005/0260259 (2005-11-01), Bolotin
patent: 2006/0003935 (2006-01-01), Pan et al.
patent: 2006/0019874 (2006-01-01), Radhakrishnan et al.
patent: 2006/0030838 (2006-02-01), Gonnelli
patent: 2006/0057137 (2006-03-01), Steiness
patent: 2006/0074025 (2006-04-01), Quay et al.
patent: 2006/0093660 (2006-05-01), Bolotin
patent: 2006/0128627 (2006-06-01), Goke et al.
patent: 2006/0172001 (2006-08-01), Ong et al.
patent: 2006/0178304 (2006-08-01), Juul-Mortensen et al.
patent: 2006/0183682 (2006-08-01), Juul-Mortensen
patent: 2006/0199763 (2006-09-01), Knudsen et al.
patent: 2006/0239924 (2006-10-01), Bolotin
patent: 2006/0247167 (2006-11-01), Schlein et al.
patent: 2006/0286129 (2006-12-01), Sarubbi
patent: 2007/0041951 (2007-02-01), Egan et al.
patent: 2007/0141006 (2007-06-01), Livoreil et al.
patent: 2007/0141145 (2007-06-01), Castillo et al.
patent: 2007/0244296 (2007-10-01), Tomalia et al.
patent: 2007/0298006 (2007-12-01), Tomalia et al.
patent: 10158195 (1998-06-01), None
patent: WO 94/05203 (1994-03-01), None
patent: WO 97/33552 (1997-09-01), None
patent: WO 98/42383 (1998-10-01), None
patent: WO 01/28569 (2001-04-01), None
patent: WO 01/39815 (2001-06-01), None
patent: WO 01/87925 (2001-11-01), None
patent: WO 03/072143 (2003-09-01), None
patent: WO 2004/022004 (2004-03-01), None
patent: WO 2004/022004 (2004-12-01), None
patent: WO 2005/084180 (2005-09-01), None
patent: WO 2005/084180 (2005-12-01), None
patent: WO 2007/024899 (2007-03-01), None
patent: WO 2007/030706 (2007-03-01), None
patent: WO 2007/048190 (2007-05-01), None
patent: WO 2007/056681 (2007-05-01), None
patent: WO 2007/082331 (2007-07-01), None
patent: WO 2007/024899 (2007-11-01), None
Ahrén, et al. Improved glucose tolerance and insulin secretion by inhibition of dipeptidyl peptidase IV in mice. Eur. J. Pharmacol. 2000; 404(1-2):239-45.
Barton. Protective Group in Organic Chemistry. Chapter 2. MeOrnie, ed. Plenum Press. New York, 1973.
Bogdanov, et al. A new macromolecule as a contrast agent for MR angiography: preparation, properties, and animal studies. Radiology. 1993; 187(3):701-6.
Bogdanov, et al. Long-circulating blood pool imaging agents. Adv Drug Del Revs. 1995; 16:335-348.
Bonner-Weir, et al. Imaging the Pancreatic Beta Cell. 1999; http://www.niddk.nih.gov/fund/reports/beta—imaging—report—2.htm.
Brand, et al. Pharmacological treatment of chronic diabetes by stimulating pancreatic beta-cell regeneration with systemic co-administration of EGF and gastrin. Pharmacol Toxicol. 2002; 91(6):414-20.
Bulotta, et al. Cultured pancreatic ductal cells undergo cell cycle re-distribution and beta-cell-like differentiation in response to glucagon-like peptide-1. J. Mol. Endocrinol. 2002; 29(3):347-60.
Buteau, et al. Glucagon-like peptide-1 promotes DNA synthesis, activates phosphatidylinositol 3-kinase and increases transcription factor pancreatic and duodenal homeobox gene 1 (PDX-1) DNA binding activity in beta (INS-1)-cells. Diabetologia. 1999; 42(7):856-64.
Callahan, et al. Preclinical evaluation and phase I clinical trial of a 99mTc-labeled synthetic polymer used in blood pool imaging. AJR Am J Roentgenol. 1998; 171(1):137-43.
Clark, D. Guide for Care of Use of Laboratory Animals. National Research Council. 1996, pp. i-xii and 1-128.
Druncker, D. Enhancing incretin action for the treatment of type 2 diabetes. Diabetes Care. 2003; 26(10):2929-40.
Ettaro, et al. Cost-of-illness studies in diabetes mellitus. Pharmacoeconomics. 2004; 22(3):149-64.
Farilla, et al. Glucagon-like peptide 1 inhibits cell apoptosis and improves glucose responsiveness of freshly isolated human islets. Endocrinology. 2003; 144(12):5149-58.
Gappa, et al. The effect of zinc-crystallized glucagon-like peptide-1 on insulin secretion of macroencapsulated pancreatic islets. Tissue Eng. 2001; 7(1):35-44.
Greene, et al. Protecive Groups in Organic Synthesis. Wil
Bolotin Elijah M.
Castillo Gerardo M.
Castillo Gerardo M.
Jones D L
Pharmain Corporation
Roche Anie K.
Wilson Sonsini Goodrich & Rosati
LandOfFree
Compositions for delivery of therapeutics and other materials does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Compositions for delivery of therapeutics and other materials, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compositions for delivery of therapeutics and other materials will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4118572